HZNP - Horizon Therapeutics Plc
IEX Last Trade
104.06
2.920 2.806%
Share volume: 3,831,115
Last Updated: Tue 08 Aug 2023 09:59:57 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$101.14
2.92
2.89%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-04 | 2022-08-03 | 2022-11-02 | 2023-03-01 | 2023-05-03 | 2023-08-08 | |
| Assets | |||||||
| Total Assets | 8.740 B | 8.853 B | 9.028 B | 9.115 B | 8.993 B | 9.299 B | |
| Current Assets | 2.948 B | 3.203 B | 3.412 B | 3.653 B | 3.603 B | 3.922 B | |
| Inventories | 226.524 M | 203.680 M | 190.258 M | 169.559 M | 164.496 M | 170.325 M | |
| Other Current Assets | 361.055 M | 403.217 M | 414.989 M | 421.122 M | 467.729 M | 532.918 M | |
| Short Term Investments | 361.055 M | 403.217 M | 414.989 M | 421.122 M | 467.729 M | 532.918 M | |
| Total Receivables | 684.507 M | 673.307 M | 646.386 M | 676.347 M | 624.697 M | 717.417 M | |
| Current Cash | 1.643 B | 1.893 B | 2.131 B | 2.353 B | 2.312 B | 2.465 B | |
| Total Non-current Assets | 5.793 B | 5.650 B | 5.616 B | 5.462 B | 5.391 B | 5.377 B | |
| Property Plant Equipment | 295.147 M | 302.260 M | 317.692 M | 340.509 M | 355.872 M | 362.326 M | |
| Other Assets | 162.455 M | 160.621 M | 203.612 M | 204.135 M | 187.811 M | 263.042 M | |
| Intangible Assets | 3.752 B | 3.661 B | 3.568 B | 3.475 B | 3.386 B | 3.297 B | |
| Goodwill | 1.067 B | 1.011 B | 1.011 B | 1.011 B | 1.011 B | 1.011 B | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 8.740 B | 8.853 B | 9.028 B | 9.115 B | 8.993 B | 9.299 B | |
| Total liabilities | 3.923 B | 3.908 B | 3.994 B | 4.042 B | 3.898 B | 3.988 B | |
| Total current liabilities | 825.179 M | 791.061 M | 860.614 M | 949.137 M | 884.888 M | 917.681 M | |
| Accounts Payable | 67.014 M | 18.538 M | 32.113 M | 155.800 M | 76.619 M | 85.543 M | |
| Other liabilities | 209.811 M | 199.645 M | 199.300 M | 204.451 M | 197.222 M | 263.828 M | |
| Current long term debt | 16.000 M | 16.000 M | 16.000 M | 16.000 M | 16.000 M | 16.000 M | |
| Long term debt | 2.553 B | 2.551 B | 2.549 B | 2.547 B | 2.544 B | 2.541 B | |
| Other liabilities | 209.811 M | 199.645 M | 199.300 M | 204.451 M | 197.222 M | 263.828 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.818 B | 4.946 B | 5.034 B | 5.072 B | 5.096 B | 5.311 B | |
| Common stock | 229.094 M | 230.020 M | 230.333 M | 226.988 M | 228.398 M | 228.743 M | |
| Retained earnings | 522.866 M | 583.840 M | 606.280 M | 590.009 M | 644.693 M | 771.764 M |